EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 128 filers reported holding EPIZYME INC in Q2 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $120,000 | -54.7% | 13,766 | -38.1% | 0.01% | -67.4% |
| Q3 2020 | $265,000 | +24.4% | 22,251 | +29.4% | 0.04% | +22.9% |
| Q1 2019 | $213,000 | -38.3% | 17,201 | -32.4% | 0.04% | -32.7% |
| Q2 2018 | $345,000 | -24.8% | 25,453 | +5.6% | 0.05% | -29.7% |
| Q3 2017 | $459,000 | +341.3% | 24,104 | +136.1% | 0.07% | +164.3% |
| Q2 2016 | $104,000 | – | 10,208 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |